Services

Scope of Services and Department Highlights

The Department of Medical Oncology at St. John’s registers, on average, 1,000 new patients each year, reflecting its pivotal role in cancer care within the region. Outpatient services see nearly 12,000 attendances annually, demonstrating the department’s extensive reach and commitment to ongoing patient support.

A comprehensive day care service operates within the department, administering approximately 500 chemotherapy and targeted therapy infusions each month. This facility ensures that patients receive timely and effective treatments in a supportive environment.

The department’s offerings encompass routine oncology-related diagnostic tests and stem cell transplants. In 2023-24, the department advanced its therapeutic capabilities with the introduction of state-of-the-art treatments, including use of Chimeric Antigen Receptor T-cell (CART), immunotherapy, antibody Drug Conjugates (ADC), and bispecific antibody administrations.

To deliver holistic and tailored care, the department has established organ-based tumour boards. These multidisciplinary panels facilitate comprehensive cancer management and informed decision-making for all patients presenting to the Oncology Centre.

The academic programme, initiated in 2025, admits two DNB Medical Oncology candidates per year. Additionally, the department actively engages in research, both independently and through collaborative efforts, contributing to clinical and investigator-initiated trials aimed at advancing cancer treatment and patient outcomes.

Uniqueness of Service

The Department of Medical Oncology’s approach is deeply aligned with the institutional motto, “He shall live because of me”, highlighting its commitment to patient-centred care. The department is dedicated to delivering compassionate and high-quality cancer treatment to individuals from diverse backgrounds and all levels of society. This inclusive philosophy ensures that every patient receives care tailored to their needs, regardless of their circumstances.

Beyond medical interventions, the department collaborates closely with social workers and non-governmental organisations to guarantee that patients and survivors have equitable and timely access to advanced therapies. These partnerships also provide essential social and financial support, easing the burdens often faced by those affected by cancer.

In addition, the Department actively engages in community outreach initiatives aimed at raising cancer awareness. By promoting education and understanding within the broader community, these programmes help foster early detection and encourage support for individuals undergoing treatment as well as survivors.